These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1322 related items for PubMed ID: 8982148

  • 41. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea.
    Ballas SK, Marcolina MJ, Dover GJ, Barton FB.
    Br J Haematol; 1999 May; 105(2):491-6. PubMed ID: 10233426
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective.
    Sharef SW, Al-Hajri M, Beshlawi I, Al-Shahrabally A, Elshinawy M, Zachariah M, Mevada ST, Bashir W, Rawas A, Taqi A, Al-Lamki Z, Wali Y.
    Eur J Haematol; 2013 Jun; 90(6):519-24. PubMed ID: 23489171
    [Abstract] [Full Text] [Related]

  • 47. Magnesium for treating sickle cell disease.
    Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L.
    Cochrane Database Syst Rev; 2017 Apr 14; 4(4):CD011358. PubMed ID: 28409830
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH, Al-Dabbous IA.
    Saudi Med J; 2002 Mar 14; 23(3):277-81. PubMed ID: 11938415
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.
    Keikhaei B, Yousefi H, Bahadoram M.
    Glob J Health Sci; 2015 Aug 19; 8(3):252-6. PubMed ID: 26493428
    [Abstract] [Full Text] [Related]

  • 54. Magnesium for treating sickle cell disease.
    Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L.
    Cochrane Database Syst Rev; 2019 Sep 09; 9(9):CD011358. PubMed ID: 31498421
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
    Luchtman-Jones L, Pressel S, Hilliard L, Brown RC, Smith MG, Thompson AA, Lee MT, Rothman J, Rogers ZR, Owen W, Imran H, Thornburg C, Kwiatkowski JL, Aygun B, Nelson S, Roberts C, Gauger C, Piccone C, Kalfa T, Alvarez O, Hassell K, Davis BR, Ware RE.
    Am J Hematol; 2016 Feb 09; 91(2):238-42. PubMed ID: 26615793
    [Abstract] [Full Text] [Related]

  • 57. Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
    Rigano P, De Franceschi L, Sainati L, Piga A, Piel FB, Cappellini MD, Fidone C, Masera N, Palazzi G, Gianesin B, Forni GL, Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators.
    Blood Cells Mol Dis; 2018 Mar 09; 69():82-89. PubMed ID: 29107441
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 67.